Export 15 results:
Author [ Title(Desc)] Type Year
Filters: Author is El-Khorazaty, Jill  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
M. M. Venkatesan, Ballou, C., Barnoy, S., McNeal, M., El-Khorazaty, J., Frenck, R., and Baqar, S., “Antibody in Lymphocyte Supernatant (ALS) responses after oral vaccination with live Shigella sonnei vaccine candidates WRSs2 and WRSs3 and correlation with serum antibodies, ASCs, fecal IgA and shedding.”, PLoS One, vol. 16, no. 11, p. e0259361, 2021.
D
N. Rouphael, Beck, A., Kirby, A. E., Liu, P., Natrajan, M. S., Lai, L., Phadke, V., Winston, J., Raabe, V., Collins, M. H., Girmay, T., Alvarez, A., Beydoun, N., Karmali, V., Altieri-Rivera, J., Lindesmith, L. C., Anderson, E. J., Wang, Y., El-Khorazaty, J., Petrie, C., Baric, R. S., Baqar, S., Moe, C. L., and Mulligan, M. J., “Dose-Response of a Norovirus GII.2 Controlled Human Challenge Model Inoculum.”, J Infect Dis, 2022.
E
E. J. Anderson, Lopman, B., Yi, J., Libster, R., C Creech, B., El-Khorazaty, J., Baqar, S., Yildirim, I., Kao, C., Rouphael, N., Shane, A. L., and Edwards, K., “Effect of Concomitant Antibiotic and Vaccine Administration on Serologic Responses to Rotavirus Vaccine.”, J Pediatric Infect Dis Soc, vol. 9, no. 4, pp. 479-482, 2020.
H
A. E. Fombah, Goldstein, S. T., Jarrett, O. D., Jalloh, M. I., El-Khorazaty, J., Lisk, D. Radcliffe, Legardy-Williams, J., Pratt, D. A., George, P. M., Russell, J. B. W., Schrag, S. J., Dawson, P., Deen, G. F., Carr, W., Lindblad, R., James, F., Bah, M. M., Yillia, J. F., Sandy, J. D., Turay, P. E., Conteh, M. - A., Slutsker, L., Mahon, B. E., Samai, M., and Seward, J. F., “Health Conditions in an Adult Population in Sierra Leone: Data Reported From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).”, J Infect Dis, vol. 217, no. suppl_1, pp. S75-S80, 2018.
L
H. Allewelt, El-Khorazaty, J., Mendizabal, A., Taskindoust, M., Martin, P. L., Prasad, V., Page, K., Sanders, J., and Kurtzberg, J., “Late Effects after Umbilical Cord Blood Transplantation in Very Young Children after Busulfan-Based, Myeloablative Conditioning.”, Biol Blood Marrow Transplant, vol. 22, no. 9, pp. 1627-1635, 2016.
M
O. D. Jarrett, Seward, J. F., Fombah, A. E., Lindblad, R., Jalloh, M. I., El-Khorazaty, J., Dawson, P., Burton, D., Zucker, J., Carr, W., Bah, M. M., Deen, G. F., George, P. M., James, F., Lisk, D. R., Pratt, D., Russell, J. B. W., Sandy, J. D., Turay, P., Hamel, M. J., Schrag, S. J., Walker, R. E., Samai, M., and Goldstein, S. T., “Monitoring Serious Adverse Events in the Sierra Leone Trial to Introduce a Vaccine Against Ebola.”, J Infect Dis, vol. 217, no. suppl_1, pp. S24-S32, 2018.
P
D. I. Bernstein, Pasetti, M. F., Brady, R., Buskirk, A. D., Wahid, R., Dickey, M., Cohen, M., Baughman, H., El-Khorazaty, J., Maier, N., Sztein, M. B., Baqar, S., and A Bourgeois, L., “A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization.”, Vaccine, vol. 37, no. 4, pp. 602-611, 2019.
R. W. Frenck, Baqar, S., Alexander, W., Dickey, M., McNeal, M., El-Khorazaty, J., Baughman, H., Hoeper, A., Barnoy, S., Suvarnapunya, A. E., Kaminski, R. W., and Venkatesan, M. M., “A Phase I trial to evaluate the safety and immunogenicity of WRSs2 and WRSs3; two live oral candidate vaccines against Shigella sonnei.”, Vaccine, vol. 36, no. 32 Pt B, pp. 4880-4889, 2018.
R
J. M. Hare, DiFede, D. L., Rieger, A. C., Florea, V., Landin, A. M., El-Khorazaty, J., Khan, A., Mushtaq, M., Lowery, M. H., Byrnes, J. J., Hendel, R. C., Cohen, M. G., Alfonso, C. E., Valasaki, K., Pujol, M. V., Golpanian, S., Ghersin, E., Fishman, J. E., Pattany, P., Gomes, S. A., Delgado, C., Miki, R., Abuzeid, F., Vidro-Casiano, M., Premer, C., Medina, A., Porras, V., Hatzistergos, K. E., Anderson, E., Mendizabal, A., Mitrani, R., and Heldman, A. W., “Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial.”, J Am Coll Cardiol, vol. 69, no. 5, pp. 526-537, 2017.
S
S. A. Jongo, Church, L. W. Preston, Mtoro, A. T., Chakravarty, S., Ruben, A. J., Swanson, P. A., Kassim, K. R., Mpina, M., Tumbo, A. - M., Milando, F. A., Qassim, M., Juma, O. A., Bakari, B. M., Simon, B., James, E. R., Abebe, Y., Kc, N., Saverino, E., Gondwe, L., Studer, F., Fink, M., Cosi, G., El-Khorazaty, J., Styers, D., Seder, R. A., Schindler, T., Billingsley, P. F., Daubenberger, C., B Sim, K. Lee, Tanner, M., Richie, T. L., Abdulla, S., and Hoffman, S. L., “Safety and Differential Antibody and T-Cell Responses to the Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants.”, Am J Trop Med Hyg, vol. 100, no. 6, pp. 1433-1444, 2019.
S. A. Jongo, Church, L. W. Preston, Mtoro, A. T., Chakravarty, S., Ruben, A. J., Swanson, P. A., Kassim, K. R., Mpina, M., Tumbo, A. - M., Milando, F. A., Qassim, M., Juma, O. A., Bakari, B. M., Simon, B., James, E. R., Abebe, Y., Kc, N., Saverino, E., Gondwe, L., Studer, F., Fink, M., Cosi, G., El-Khorazaty, J., Styers, D., Seder, R. A., Schindler, T., Billingsley, P. F., Daubenberger, C., B Sim, K. Lee, Tanner, M., Richie, T. L., Abdulla, S., and Hoffman, S. L., “Safety and Differential Antibody and T-Cell Responses to the Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants.”, Am J Trop Med Hyg, vol. 100, no. 6, pp. 1433-1444, 2019.
S. A. Jongo, Church, L. W. Preston, Mtoro, A. T., Chakravarty, S., Ruben, A. J., Swanson, P. A., Kassim, K. R., Mpina, M., Tumbo, A. - M., Milando, F. A., Qassim, M., Juma, O. A., Bakari, B. M., Simon, B., James, E. R., Abebe, Y., Kc, N., Saverino, E., Gondwe, L., Studer, F., Fink, M., Cosi, G., El-Khorazaty, J., Styers, D., Seder, R. A., Schindler, T., Billingsley, P. F., Daubenberger, C., B Sim, K. Lee, Tanner, M., Richie, T. L., Abdulla, S., and Hoffman, S. L., “Safety and Differential Antibody and T-Cell Responses to the Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants.”, Am J Trop Med Hyg, vol. 100, no. 6, pp. 1433-1444, 2019.
S. A. Jongo, Church, L. W. Preston, Mtoro, A. T., Chakravarty, S., Ruben, A. J., Swanson, P. A., Kassim, K. R., Mpina, M., Tumbo, A. - M., Milando, F. A., Qassim, M., Juma, O. A., Bakari, B. M., Simon, B., James, E. R., Abebe, Y., Kc, N., Saverino, E., Gondwe, L., Studer, F., Fink, M., Cosi, G., El-Khorazaty, J., Styers, D., Seder, R. A., Schindler, T., Billingsley, P. F., Daubenberger, C., B Sim, K. Lee, Tanner, M., Richie, T. L., Abdulla, S., and Hoffman, S. L., “Safety and Differential Antibody and T-Cell Responses to the Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants.”, Am J Trop Med Hyg, vol. 100, no. 6, pp. 1433-1444, 2019.
W. H. Chen, Pasetti, M. F., Adhikari, R. P., Baughman, H., Douglas, R., El-Khorazaty, J., Greenberg, N., Holtsberg, F. W., Liao, G. C., Reymann, M. K., Wang, X., Warfield, K. L., and M Aman, J., “Safety and Immunogenicity of a Parenterally Administered, Structure-Based Rationally Modified Recombinant Staphylococcal Enterotoxin B Protein Vaccine, STEBVax.”, Clin Vaccine Immunol, vol. 23, no. 12, pp. 918-925, 2016.
R. Libster, McNeal, M., Walter, E. B., Shane, A. L., Winokur, P., Cress, G., Berry, A. A., Kotloff, K. L., Sarpong, K., Turley, C. B., Harrison, C. J., Pahud, B. A., Marbin, J., Dunn, J., El-Khorazaty, J., Barrett, J., and Edwards, K. M., “Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules.”, Pediatrics, vol. 137, no. 2, p. e20152603, 2016.